Nexavar impresses in clinical trials
Patients who received Nexavar along with the chemo drug Xeloda had a 74 percent improvement in the amount of time they lived without a disease progression, researchers found.
More... |
All times are GMT -7. The time now is 02:55 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021